Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Living Cell Technologies Ltd. (LVCLF)
OTHER OTC:LVCLF
Living Cell Technologies Ltd. (LVCLF) Stock Price & Analysis
1 Followers
LVCLF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range<$0.01 - $0.02
Previous Close$0.01
Volume47.83K
Average Volume (3M)N/A
Market Cap
$10.23M
Enterprise Value$7.36M
Total Cash (Recent Filing)AU$4.24M
Total Debt (Recent Filing)AU$0.00
Price to Earnings (P/E)―
Beta0.06
Next Earnings
Aug 28, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding1,635,646,450
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard Deviation0.28
R-Squared0.02
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Living Cell Technologies Ltd. News
PremiumCompany Announcements
Algorae Pharmaceuticals Appoints New Secretary
PremiumCompany Announcements
ALGORAE Eyes Expansion with New ASX Listing
PremiumCompany Announcements
Algorae Pharmaceuticals Announces Secretary Change
PremiumCompany Announcements
ALGORAE Eyes Expansion with New Share Quotation
PremiumCompany Announcements
ALGORAE Pharma Announces New Securities Issue
PremiumCompany Announcements
ALGORAE Eyes Growth with New ASX Shares
PremiumCompany Announcements
ALGORAE Ends Trading of Select Securities
PremiumCompany Announcements
Algorae Pharmaceuticals Shares Corporate UpdateOptions Prices
Currently, No data available
---
Ownership Overview
7.18% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
92.82% Public Companies and
Individual Investors
LVCLF FAQ
What was Living Cell Technologies Ltd.’s price range in the past 12 months?
Living Cell Technologies Ltd. lowest stock price was <$0.01 and its highest was $0.02 in the past 12 months.
What is Living Cell Technologies Ltd.’s market cap?
Currently, no data Available
When is Living Cell Technologies Ltd.’s upcoming earnings report date?
Living Cell Technologies Ltd.’s upcoming earnings report date is Aug 28, 2024 which is in 40 days.
How were Living Cell Technologies Ltd.’s earnings last quarter?
Living Cell Technologies Ltd. released its earnings results on Feb 28, 2024. The company reported >-$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by >-$0.001.
Is Living Cell Technologies Ltd. overvalued?
According to Wall Street analysts Living Cell Technologies Ltd.’s price is currently Overvalued.
Does Living Cell Technologies Ltd. pay dividends?
Living Cell Technologies Ltd. does not currently pay dividends.
What is Living Cell Technologies Ltd.’s EPS estimate?
Living Cell Technologies Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Living Cell Technologies Ltd. have?
Living Cell Technologies Ltd. has 1,687,394,800 shares outstanding.
What happened to Living Cell Technologies Ltd.’s price movement after its last earnings report?
Living Cell Technologies Ltd. reported an EPS of >-$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Living Cell Technologies Ltd.?
Currently, no hedge funds are holding shares in LVCLF
---
Living Cell Technologies Ltd. Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
―
20 days / 200 days
Momentum
9.09%
12-Months-Change
Fundamentals
Return on Equity
-68.84%
Trailing 12-Months
Asset Growth
21.41%
Trailing 12-Months
Company Description
Living Cell Technologies Ltd.
Living Cell Technologies Ltd. is a biotechnology company. It engages in the development of treatments for implanting healthy living cells to replace or repair diseased or damaged organs for life threatening diseases. The company was founded by Robert Bartlett Elliot and David Collinson in 1987 and is headquartered in Auckland, New Zealand.
---
Technical Analysis
Creative Medical Technology Holdings
―
Genetic Technologies
―
Brainstorm Cell Therapeutics
―
---